Abstract
Tumour necrosis factor-α inhibitors (TNFi) are immunosuppressive therapies that are known to increase infectious risk. Indeed, patients affected by TNFi requiring conditions are at higher risk of influenza compared with...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have